FibroGen (FGEN) Tops Q1 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. BROS
3. ARM
4. FIS
5. QCOM
6. EXPE
7. CPAY
8. PAYC
9. SNAP
10. FSLY

Go back to FibroGen (FGEN) Tops Q1 EPS by 11c

FibroGen Reports Financial Results for the First Quarter of 2016

May 9, 2016 4:02 PM EDT

Continued Progress in Roxadustat Phase 3 Studies; Promising Interim Pancreatic Cancer Data

Webcast Conference Call Scheduled for 4:30pm EST Today

SAN FRANCISCO, May 09, 2016 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) (FibroGen), a research-based biopharmaceutical company, today reported financial results for the quarter ended March 31, 2016.

We are pleased with the progress of our major development programs across the board, said Thomas B. Neff, chief executive officer of FibroGen. FibroGen and our collaboration partners continue to advance the roxadustat global Phase 3 program in... More